| (Values in U.S. Thousands) | Feb, 2026 | Nov, 2025 | Aug, 2025 | May, 2025 | Feb, 2025 |
| Sales | 990 | 1,210 | 1,380 | 750 | 1,120 |
| Sales Growth | -18.18% | -12.32% | +84.00% | -33.04% | -31.71% |
| Net Income | -1,310 | -1,320 | 0 | -1,540 | -1,160 |
| Net Income Growth | +0.76% | unch | +100.00% | -32.76% | -22.11% |
Biomerica Inc (BMRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
BIOMERICA, INC. is an emerging-growth biotechnology firm that develops, manufactures and distributes medical diagnostic products. The Company is focused on niche products for early detection and monitoring of human diseases and conditions before they become catastrophic and incurable. The customers include medical universities, pharmaceutical companies, hospitals, clinics, commercial laboratories, physician's offices and consumers.
Fiscal Year End Date: 05/31